XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues      
Total Revenues $ 4,689.7 $ 4,883.6 $ 4,868.0
Expenses      
Compensation and benefits 837.0 856.5 898.7
Technology 192.6 198.5 201.5
Professional fees and outside services 151.7 191.3 174.1
Amortization of purchased intangibles 237.6 311.2 314.7
Depreciation and amortization 147.8 153.2 158.6
Licensing and other fee agreements 236.9 244.9 172.2
Other 240.9 290.6 360.4
Total Expenses 2,044.5 2,246.2 2,280.2
Operating Income 2,645.2 2,637.4 2,587.8
Non-Operating Income (Expense)      
Investment income 306.9 182.7 637.9
Interest and other borrowing costs (166.9) (166.2) (178.0)
Equity in net earnings (losses) of unconsolidated subsidiaries 245.8 190.6 176.8
Other income (expense) 342.6 (122.4) (534.9)
Total Non-Operating 728.4 84.7 101.8
Income before Income Taxes 3,373.6 2,722.1 2,689.6
Income tax provision 736.7 615.7 573.8
Net income 2,636.9 2,106.4 2,115.8
Net Income (Loss) Attributable to Noncontrolling Interest 0.5 1.2 (0.7)
Net income attributable to CME Group 2,636.4 2,105.2 2,116.5
Net Income Attributable to Common Shareholders of CME Group $ 2,617.1 $ 2,105.2 $ 2,116.5
Earnings per Common Share Attributable to CME Group:      
Basic $ 7.30 $ 5.88 $ 5.93
Diluted $ 7.29 $ 5.87 $ 5.91
Weighted Average Number of Common Shares:      
Basic 358,340 357,764 357,155
Diluted 358,929 358,524 358,239
Clearing and Transaction Fees [Member]      
Revenues      
Total Revenues $ 3,765.1 $ 3,897.4 $ 3,946.1
MarketData [Member]      
Revenues      
Total Revenues 576.9 545.4 518.5
OtherRevenue [Member]      
Revenues      
Total Revenues $ 347.7 $ 440.8 $ 403.4